MedPath

Comparison of endotracheal tube and thin catheter for surfactant therapy in neonates with respiratory distress syndrome

Phase 3
Conditions
Respiratory distress syndrome.
Respiratory distress syndrome of newborn
P22.0
Registration Number
IRCT20211006052685N2
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Infants born with a gestational age of 25 to 37 weeksA
dmitted to the NIC

Exclusion Criteria

Respiratory distress due to cardiac causes
hemodynamic instability
sepsis and any cause other than surfactant deficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment of respiratory distress syndrome. Timepoint: Evaluate respiratory condition of neonates at birth up to 30 days after birth. Method of measurement: Evaluate the duration and amount of need for mechanical ventilation, NCPAP and FiO2.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath